LINC01232 and nonpapillary renal cell carcinoma: In addition to ccRCC and KIRP, the significantly increased LINC01232 expression was also found in colon adenocarcinoma (COAD; Figure S2(a), p < .001), oesophageal carcinoma (ESCA; Figure S2(b), p < .01), lung squamous cell carcinoma (LUSC; Figure S2(c), p < .001) and prostate adenocarcinoma (PRAD; Figure S2(d), p < .001).